Greetings from Editor-in-Chief and Editorial Office of Annals of Pancreatic Cancer!
Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Annals of Pancreatic Cancer (APC) is among the list of COPE membership.
On June 26, 2021, we received the good news from Elsevier that Annals of Pancreatic Cancer (APC) has been accepted for inclusion in Scopus.
With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to implement a transparent peer review process as an option for all manuscripts submitted to APC from June 11, 2020.
AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.
APC Annual Report 2019
Annals of Pancreatic Cancer welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.
APC Annual Report 2018
Join us at the 2018 ACS Clinical Congress, Boston, USA
Abstracts for Pancreas 2018, Innovations in the Care of Pancreatic Cancer
Welcome to Pancreas 2018 Innovations in the Care of Pancreatic Cancer and Call for Papers
1 - 11 of 11 Items